Tumor boards, also known as multidisciplinary cancer conferences, provide prospective patient case review and assure quality of care evaluation related to diagnosis, treatment, symptom management, follow-up, prehabilitation and/or rehabilitation, and supportive care. Discussion includes, but is not limited to, sharing of expert clinical opinions and treatment recommendations; treatment decision made by attending physician and patient; and opportunities for clinical trial participation.
Disease-site-specific tumor boards focus on certain cancers, for example, breast cancer, lung cancer, prostate cancer, head and neck cancer.
Molecular tumor board discussion centers around molecular biomarkers and appropriate treatments and clinical trials for patients with tumors that have these markers.
Building on interviews with select ACCC member programs, ACCC and our partner organization, the Association for Molecular Pathology (AMP), developed a webinar series focused on virtual molecular tumor boards for lung and breast cancer. The 12-webinar series features case studies and robust discussions on molecular testing in the community setting.